No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized* / administration & dosage
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Antibodies, Monoclonal, Humanized* / pharmacokinetics
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Clonidine / administration & dosage
-
Clonidine / adverse effects
-
Clonidine / analogs & derivatives*
-
Clonidine / pharmacokinetics
-
Clonidine / therapeutic use
-
Dibenzothiepins
-
Drug Interactions
-
Humans
-
Influenza, Human / drug therapy*
-
Migraine Disorders / drug therapy*
-
Morpholines
-
Oxazines* / administration & dosage
-
Oxazines* / adverse effects
-
Oxazines* / pharmacokinetics
-
Oxazines* / therapeutic use
-
Pyridines* / administration & dosage
-
Pyridines* / adverse effects
-
Pyridines* / pharmacokinetics
-
Pyridines* / therapeutic use
-
Pyridones
-
Substance Withdrawal Syndrome / drug therapy*
-
Thiepins* / administration & dosage
-
Thiepins* / adverse effects
-
Thiepins* / pharmacokinetics
-
Thiepins* / therapeutic use
-
Triazines* / administration & dosage
-
Triazines* / adverse effects
-
Triazines* / pharmacokinetics
-
Triazines* / therapeutic use
Substances
-
Antibodies, Monoclonal, Humanized
-
Dibenzothiepins
-
Morpholines
-
Oxazines
-
Pyridines
-
Pyridones
-
Thiepins
-
Triazines
-
baloxavir
-
erenumab
-
Clonidine
-
lofexidine